Bausch + Lomb (NYSE:BLCO) Stock Price Target Raised at Royal Bank Of Canada

Key Points

• Royal Bank of Canada raised Bausch + Lomb’s price target from $21 to $23 and maintained an “outperform” rating, implying approximately 12% upside from the stock’s price at the time.
• Analyst sentiment remains mixed: the consensus rating is “Hold,” with a $20 average target price, while ratings include one Strong Buy, six Buys, seven Holds, and one Sell.
• Bausch + Lomb reported quarterly adjusted earnings of $0.34 per share, beating the $0.21 consensus estimate, while revenue rose 7.3% year over year to $1.38 billion.

Bausch + Lomb (NYSE:BLCO - Get Free Report) had its price objective raised by equities research analysts at Royal Bank Of Canada from $21.00 to $23.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Royal Bank Of Canada's target price would suggest a potential upside of 12.04% from the stock's current price.

Several other analysts also recently commented on BLCO. Evercore set a $17.00 target price on shares of Bausch + Lomb in a research report on Monday, July 6th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $20.00 price objective on shares of Bausch + Lomb in a research note on Thursday. Citigroup restated a "buy" rating on shares of Bausch + Lomb in a report on Thursday. Wells Fargo & Company upped their target price on shares of Bausch + Lomb from $18.00 to $19.00 and gave the company an "equal weight" rating in a research report on Thursday. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Bausch + Lomb in a research report on Tuesday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $20.00.

Bausch + Lomb Stock Up 0.6%

BLCO stock traded up $0.13 during trading on Thursday, reaching $20.53. The stock had a trading volume of 2,654,697 shares, compared to its average volume of 462,677. The company has a current ratio of 1.55, a quick ratio of 1.02 and a debt-to-equity ratio of 0.79. The firm has a fifty day moving average price of $17.24 and a 200 day moving average price of $16.66. The company has a market capitalization of $7.34 billion, a P/E ratio of -42.60, a PEG ratio of 0.55 and a beta of 0.56. Bausch + Lomb has a 1-year low of $14.44 and a 1-year high of $21.36.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.13. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.37 billion. Bausch + Lomb had a negative net margin of 3.21% and a positive return on equity of 4.14%. The company's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.18 EPS. On average, equities analysts anticipate that Bausch + Lomb will post 0.81 earnings per share for the current year.

Insiders Place Their Bets

In other Bausch + Lomb news, CAO Frederick Munsch sold 52,900 shares of the business's stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $16.78, for a total transaction of $887,662.00. Following the completion of the transaction, the chief accounting officer directly owned 45,831 shares in the company, valued at $769,044.18. The trade was a 53.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Eschenbach Andrew C. Von sold 12,500 shares of the firm's stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $16.50, for a total value of $206,250.00. Following the completion of the sale, the director directly owned 69,792 shares in the company, valued at $1,151,568. This trade represents a 15.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 71,459 shares of company stock worth $1,194,370 in the last 90 days. 1.45% of the stock is owned by company insiders.

Hedge Funds Weigh In On Bausch + Lomb

A number of hedge funds have recently made changes to their positions in BLCO. Whitebox Advisors LLC raised its position in shares of Bausch + Lomb by 15.8% in the 1st quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company's stock worth $17,519,000 after acquiring an additional 150,641 shares in the last quarter. Beach Point Capital Management LP bought a new position in shares of Bausch + Lomb during the 3rd quarter worth approximately $5,882,000. Sei Investments Co. grew its position in shares of Bausch + Lomb by 100.0% during the 1st quarter. Sei Investments Co. now owns 139,266 shares of the company's stock worth $2,214,000 after buying an additional 69,633 shares during the period. Engineers Gate Manager LP bought a new position in Bausch + Lomb during the second quarter worth $1,479,000. Finally, Dimensional Fund Advisors LP grew its holdings in Bausch + Lomb by 13.2% in the first quarter. Dimensional Fund Advisors LP now owns 85,779 shares of the company's stock worth $1,362,000 after purchasing an additional 9,971 shares during the period. 11.07% of the stock is currently owned by institutional investors.

Key Bausch + Lomb News

Here are the key news stories impacting Bausch + Lomb this week:

• Positive Sentiment: Q3 earnings beat expectations: Adjusted EPS was $0.34, well above the $0.21–$0.22 analyst consensus and up from $0.18 a year earlier. Revenue reached approximately $1.38 billion, slightly ahead of estimates and 7.3% higher year over year. Bausch + Lomb Q3 earnings beat estimates
• Positive Sentiment: Full-year guidance was raised: Management now expects 2026 revenue of $5.450 billion to $5.550 billion and adjusted EBITDA of $1.090 billion to $1.140 billion, citing continued momentum from its Vision ’27 strategy and growth in eye-care products. Bausch + Lomb raises 2026 guidance
• Positive Sentiment: Profitability improved: The company swung to a quarterly profit on an adjusted basis, with earnings growth outpacing revenue growth. This stronger operating performance is the primary reason investors are reacting favorably to the latest updates. Bausch + Lomb swings to profit and raises guidance

About Bausch + Lomb

Bausch + Lomb Corporation NYSE: BLCO is a global eye-health company that develops, manufactures and markets products for vision care, ophthalmic pharmaceuticals and eye surgery. The company serves consumers, eye-care professionals, hospitals and surgical centers through a portfolio spanning contact lenses, contact-lens care products, prescription medicines, over-the-counter eye-care products and surgical equipment.

Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as solutions and other products used to clean and maintain contact lenses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.